Literature DB >> 19737277

Hypogonadism-related symptoms: development and evaluation of an empirically derived self-rating instrument (HRS 'Hypogonadism Related Symptom Scale').

J Wiltink1, M E Beutel, E Brähler, W Weidner.   

Abstract

While self-report screening instruments are highly sensitive to hypogonadism in the ageing male, they have lacked specificity as evidenced by low or absent correlations with testosterone. The purpose of this paper was to develop an economical and specific screening instrument for identifying hypogonadal ageing men. Based on a comprehensive study of physical, somatoform and affective complaints, sexual behaviour and function and hormonal parameters of 263 outpatients aged 40 years and above (M = 56.2; 40-84 years) recruited from six andrological outpatient departments in Germany, we identified those items correlating significantly with testosterone. By factor analyses, five factors were identified: 'reduced activity', 'dissatisfaction with sexual function', 'negative self-concept of physical fitness', 'reduced sexual desire' and 'hot flushes'. The corresponding scales were reliable and only moderately inter-correlated. Consistent correlations were found with the level of testosterone, ageing male scales (Androgen Deficiency in the Aging Male, Aging Male Survey), specific affective, somatoform and sexual functioning scales and potential determinants of low testosterone (body mass index, physical inactivity, etc.). While further validation is needed, the new Hypogonadism Related Symptoms Scale appears to be a promising hypogonadism screening tool.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19737277     DOI: 10.1111/j.1439-0272.2009.00930.x

Source DB:  PubMed          Journal:  Andrologia        ISSN: 0303-4569            Impact factor:   2.775


  3 in total

Review 1.  Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials.

Authors:  Landon W Trost; John P Mulhall
Journal:  J Sex Med       Date:  2016-05-18       Impact factor: 3.802

2.  Content Validity of the Hypogonadism Impact of Symptoms Questionnaire (HIS-Q): A Patient-Reported Outcome Measure to Evaluate Symptoms of Hypogonadism.

Authors:  Heather L Gelhorn; Margaret K Vernon; Katie D Stewart; Michael G Miller; Meryl Brod; Stanley E Althof; Leonard R DeRogatis; Adrian Dobs; Allen D Seftel; Dennis A Revicki
Journal:  Patient       Date:  2016-04       Impact factor: 3.883

3.  Andropause and the development of cardiovascular disease presentation-more than an epi-phenomenon.

Authors:  Ernst R Schwarz; Anita Phan; Robert D Willix
Journal:  J Geriatr Cardiol       Date:  2011-03       Impact factor: 3.327

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.